Clinical Trial Update: Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining imaging for evaluating the prevalence of transthyretin cardiac amyloidosis in patients over 65 hospitalized in cardiol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Cardiac Amyloidosis

Snippet

Sponsor: Poitiers University Hospital | Conditions: Transthyretin Cardiac Amyloidosis | Phase 3 | Status: COMPLETED